When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
VTGN - VistaGen submits guidelines for Phase 2A study of PH94B
VistaGen Therapeutics Inc.
VistaGen Therapeutics (OTC:VTGN) has submitted its proposed protocol to the FDA for a Phase 2A study of PH94B, its investigational anti-anxiety drug, for treatment of adjustment disorder with anxiety (AjDA) related to the COVID-19.
More news on: VistaGen Therapeutics, Inc., Healthcare stocks news,